(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (20) | 6 (14) | 7 (6) | 8 (3) | 9 (4) | < (49) | A (334) | B (70) | C (269) | D (140) | E (194) | F (157) | G (461) | H (72) | I (178) | J (46) | K (71) | L (86) | M (209) | N (154) | O (62) | P (276) | Q (10) | R (114) | S (496) | T (557) | U (133) | V (38) | W (306) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | ‘ (2) | “ (1)
Title Last update
A special Mini-Meet of the Working Group on Public-Private Mix for TB Prevention and Care Mon, 04/24/2023 - 07:34
A Research Agenda fro Childhood Tuberculosis Mon, 04/24/2023 - 09:34
Andrew Cross Tue, 04/25/2023 - 03:59
A research agenda for childhood tuberculosis Tue, 04/25/2023 - 05:00
Are mRNA based transcriptomic signatures ready for diagnosing TB in the clinic Thu, 06/08/2023 - 06:51
A scoping review on the risk of TB in specific population groups Thu, 06/08/2023 - 06:52
Alert: Only one week left! REGISTER NOW for the United Nations High-Level Meeting on Tuberculosis Thu, 06/22/2023 - 02:46
Annex A - Financial Bid Response Form ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:04
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:05
Annex C- List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:06
Annex D - i+solutions model long-term agreement (LTA) ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:07
Annex E - i+solutions Code of Conduct for Suppliers ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:08
Annex F - CDP Technical Tender Submission - Instructions for use ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:09
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:10
Annex H - Indicative non-binding estimated quantities of products requested ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:11
Annex I - GMSDs address list ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:12
Annex J - Global Drug Facility artwork development guidelines ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:13
Annex K - Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:19
Annex A - Financial Bid Response Form ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:48
Annex B. List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:51
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:52
Annex D. i+solutions model Long-Term Agreement (LTA) ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:53
Annex E. i+solutions Code of Conduct for suppliers ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:55
Annex F. CDP technical tender submission - instructions for use ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:56
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:56
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:57
Annex I. GMSD address list ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:58
Annex J. GDF packaging artwork development guidelines ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:59
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 09:01
Annex L. Declaration of supply restrictions for bedaquiline 100mg tablets Thu, 07/20/2023 - 09:03
Arusha Statement - Statement by Permanent Secretaries for health and national TB programme managers on accelerating ending TB in Africa Wed, 07/26/2023 - 07:34
About Wave 10 Call for Proposals Fri, 08/04/2023 - 10:32
Arusha Statement - Statement by Permanent Secretaries for health and NTP managers on accelerating ending TB in Africa Wed, 08/09/2023 - 12:19
Annex A. Financial Bid Response Form ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 05:56
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 05:59
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:00